This article was originally published here
Cancer Discov. 2021 May 14. doi: 10.1158/2159-8290.CD-ND2021-0108. Online ahead of print.
Recent research suggests that patients with chronic lymphocytic leukemia and multiple myeloma may have a diminished immune response to COVID-19 vaccination. In a pair of studies, these patients produced lower levels of SARS-CoV2 antibodies than healthy people-and responses were particularly low in certain patients, such as those actively receiving treatment.